Travere (TVTX) Director Jeffrey Meckler Exercises Options, Sells Shares

What Happened Jeffrey A. Meckler, a director of Travere Therapeutics (TVTX), reported multiple option exercises and open-market sales on 2026-09-10. The filing shows four option exercise/conversion (code M) entries totaling 40,000 option shares: two exercises that resulted in acquisition of 20,000 shares (10,000 @ $17.44 for $174,400 and 10,000 @ $26.52 for $265,200 — total cash paid $439,600) and two exercise/conversion entries of 10,000 shares each reported as dispositions at $0.00. In addition, Meckler sold 20,000 shares in open-market transactions across several trades for aggregate proceeds of approximately $1,346,107.

Key Details

• Transaction date: 2026-09-10; Form filed 2026-09-11 (timely).
• Option exercises acquired: 20,000 shares (10,000 @ $17.44; 10,000 @ $26.52); cash paid ≈ $439,600.
• Open-market sales: 20,000 shares sold in several trades; total proceeds ≈ $1,346,107. Weighted-average sale prices reported between about $65.39 and $68.09 (see filing footnotes for ranges and per-trade detail).
• Derivative/zero-proceeds entries: two 10,000-share M entries reported at $0.00 (reported as dispositions of derivative shares).
• Footnotes: Sales were made pursuant to a written Rule 10b5-1 trading plan adopted June 11, 2026 and involve shares underlying options granted May 17, 2017 and May 9, 2018. The option(s) are fully vested.
• Shares owned after the transactions: not specified in the provided excerpt of the filing.

Context

• The filing documents option exercises (M) and concurrent open-market sales; the 10b5-1 footnote indicates the sales were pre-planned, which is common for insiders managing scheduled dispositions.
• The $0.00 derivative disposition lines reflect conversion/settlement/reporting of option shares as recorded on the Form 4; the filing ties the sales to shares underlying previously granted options.
• This is routine insider activity (exercise + sales under a pre-arranged plan) rather than an unsolicited market purchase; purchases generally carry stronger immediate bullish inference than planned sales.